RA Capital Management's Oncology Portfolio

Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.

Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

Medicenna is a clinical stage, privately held, immuno-oncology company.

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.

Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.

Werewolf Therapeutics operates as an oncology biotherapeutics company.

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

CDR-Life AG is a biotech company that develops innovative therapeutic antibody fragments with a focus on immuno-oncology.

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

Genetix Biotherapeutics develops and delivers approved gene therapies for severe rare genetic diseases like sickle cell.

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).

Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Mariana Oncology is a biotechnology research industry.

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.